【財華社訊】德琪醫藥-B(06996.HK)公佈,劉翼騰先生及李甄先生鑒於集團下階段的戰略成長及彼等將投入更多時間於其他工作業務的計劃,已通知董事會彼等有意自董事會退任,且將不會尋求於股東周年大會上(將於2021年6月18日召開)分别獲續任為執行董事及非執行董事。
德琪醫藥-B(06996.HK)擬更換執董及授權代表
2021-05-31T04:09:34-04:00May 31st, 2021|
Related Posts
-
VinFast draws up grand plans, but can it make inroads in Indonesia?
April 20th, 2024 -
Hong Kong watchdog to investigate PwC audit role in Evergrande
April 20th, 2024 -
Khosla Ventures close to launching $3b fund; backs two AI startups
April 20th, 2024 -
China moves to boost foreign investment in domestic tech companies
April 20th, 2024